PYC pyc therapeutics limited

Ann: Visual Improvement in Multiple RP11 Patients, page-5

  1. 146 Posts.
    lightbulb Created with Sketch. 102
    Just my opinion but I think it’s pretty clear this treatment is going to work and it’s just a matter of ticking boxes for approval now. This awesome level of treatment response is pretty much unheard of. It has big implications for our other drugs because we now have proof of concept. Obviously they also have to be proven and go through the trials, however, if you take the kidney example. It has been proven in human tissue and primate models. The way PYC works these drug’s up leaves a very narrow window for failure. I.e. a high probability of success. Feels like we are now just going through the motions for inevitable success. Maybe I’m too optimistic apologies if so.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.16
Change
-0.025(2.11%)
Mkt cap ! $676.5M
Open High Low Value Volume
$1.19 $1.20 $1.16 $45.30K 38.23K

Buyers (Bids)

No. Vol. Price($)
1 4346 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.19 563 1
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.